Closed · MP-CPI-23-003 · CFDA 93.137 · Discretionary
National Lupus Outreach and Clinical Trial Education Program
Federal grant opportunity posted by Office of the Assistant Secretary for Health, cataloged on Grants.gov.
- $300K-$500K
- Award range
- Closed
- Status
- August 1, 2023
- Close date
- 6
- Expected awards
The verdict
National Lupus Outreach and Clinical Trial Education Program is a closed discretionary listing from Office of the Assistant Secretary for Health that offered $300,000 -- $500,000 across 6 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 429 other opportunities from Office of the Assistant Secretary for Health.
- $300K-$500K
- award range
- Closed
- application status
- 6
- expected awards
- 93.137
- CFDA program
Archived opportunity record
National Lupus Outreach and Clinical Trial Ed… is closed (last close August 1, 2023). Check the agency catalog for replacement NOFOs. Office of the Assistant Secretary for Health still indexes 429 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed August 1, 2023
Est. Total Funding
$2,000,000
Expected Awards
6
Instrument
Grant
Description
The HHS Office of Minority Health (OMH) anticipates funding projects to demonstrate the effectiveness of interventions for increasing racial and ethnic minority enrollment and retention in lupus-related clinical trials. Projects are intended to identify and sustain effective interventions that advance clinical trial diversity and to ultimately result in reduced lupus-related health disparities experienced by racial and ethnic minority populations. Black women are three times more likely to develop lupus than their White counterparts, with Hispanic, Asian, and Native American populations also at an increased risk for developing lupus. African Americans account for 43% of all lupus cases, but African American enrollment in lupus clinical trials stands at 14%. Without enrollment in clinical trials that reflect the patient population the drug is intended to treat, a drug may be less effective or not effective at treating the disease in a large number of patients. Increasing minority participation in lupus clinical trials is important for addressing lupus-related racial and ethnic health disparities. Recipients will be expected to sustain increased enrollment of racial and ethnic minorities in lupus-related clinical trials through outreach and education interventions, and public-private and community partnerships. Recipients also will assess the impact of project findings by implementing a process and outcomes evaluation for dissemination to diverse stakeholders.
Wide-open applicant board · 12 Grants.gov doors
National Lupus Outreach and Clinical Trial Ed… prints 12 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +8 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Health (HL). Only 1 other Office of the Assistant Secretary for Health listing share this exact eligibility-code string (0% of 430).
- Code 00
- State governments
- Code 01
- County governments
- Code 02
- City or township governments
- Code 04
- Special district governments
- Code 05
- Independent school districts
- Code 06
- Public / state-controlled institutions of higher education
- Code 07
- Federally recognized tribal governments
- Code 08
- Public / Indian housing authorities
- Code 11
- Native American tribal organizations (other than Federally recognized tribal governments)
- Code 12
- Nonprofits with 501(c)(3) status (other than IHEs)
- Code 13
- Nonprofits without 501(c)(3) status (other than IHEs)
- Code 20
- Private institutions of higher education
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Paul Rodriguez paul.rodriguez@hhs.gov
More from Office of the Assistant Secretary for Health
What to do next
National Lupus Outreach and Clinical Trial Ed… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 93.137 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |